News

Earlier that day, the stock surged 25.56 % to $33.85, with 52.6 million shares traded, a volume 318 % above the three‑month average. The rally followed the release of record fiscal Q4 revenue and upbeat multi‑year guidance. Planet Labs has grown 242 % since its 2021 IPO. The company’s strategic partnerships with Nvidia and Alphabet’s Google are cit...

Full article

Planet Labs PBC (NYSE: PL) reported a sharp rally in share price on Friday, closing at $26.96 after an 8.76 % gain driven by a double‑digit revenue outlook for fiscal 2027. Management forecast revenues of $415 million to $440 million, a 35 – 43 % increase from the previous year, and adjusted EBITDA that may hold flat or rise by $10 million year‑on‑...

Full article

On March 3 2026, NextNav CEO Mariam Sorond sold 69,853 shares of common stock, a transaction worth roughly $1.2 million and representing 5.21 % of her direct holdings. The sale was to meet tax‑withholding obligations linked to the vesting of equity awards. The transaction occurred amid strong price momentum: NextNav stock had surged to a 52‑week hi...

Full article

Swarmer (NASDAQ: SWMR) opened its IPO at $12.50 and surged to a high of $65.04, closing at $45.30 by Friday midday. The software firm supplies licensed solutions for unmanned systems, positioning it to win contracts for manufacturers, but its client base is limited, making it vulnerable to the loss of key customers. Revenue reported for 2025 was ap...

Full article

DocMorris AG (XSWX:DOCM) reported 2025 revenue growth of 11.1% and confirmed that it met its financial targets for the year, largely driven by a 110 % expansion in its digital services segment. The AI Health Companion has seen rapid uptake, with one‑third of app users engaging the assistant. The company’s strategic partnership with Google aims to f...

Full article

Active Energy Group PLC (AEG.L) has acquired a second energized grid‑connection asset, advancing its rapid‑growth strategy. CEO Paul Elliott outlined a target to reach 100 MW of capacity within the next 12 to 18 months, stressing that secured energized capacity shortens the revenue path and can yield income within a month for some sites. The acquis...

Full article

Sampo plc, a leading Nordic insurance group, released its 2025 annual financial report, reporting a 16 % increase in net asset value (NAV) year‑over‑year, largely driven by strong investment returns. Operating profit rose 12 %, with all business segments contributing positively. The group maintained a robust solvency position, ending the year with...

Full article

BioRestorative operates a commercial BioCosmeceutical platform and is developing therapeutic products through cell and tissue protocols. Its two core clinical development programs are the Disc/Spine Program (BRTX‑100) and the Metabolic Program (ThermoStem). BRTX‑100 is designed as a non‑surgical treatment for painful lumbosacral disc disorders and...

Full article

The company has secured alignment with the U.S. Food and Drug Administration on the design of a future Phase 3 trial for BRTX‑100, covering primary endpoints, statistical powering assumptions, dosing strategy, and the overall development framework. The FDA reported no safety concerns and confirmed that BioRestorative’s manufacturing control framewo...

Full article

BioRestorative Therapies, Inc. will present blinded data from a Phase 2 clinical trial of its hypoxic‑cultured mesenchymal stem cell product, BRTX‑100, at the 2026 Orthopaedic Research Society Annual Meeting on March 28. The study enrolled approximately 45 patients with chronic lumbar disc disease and is expected to demonstrate meaningful improveme...

Full article